ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹15 Cr | ₹16 Cr | ₹12 Cr | ₹14 Cr | ₹26 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹26 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -7.59 | |
| Mar2024 | ₹16 Cr | 34.17 | |
| Mar2023 | ₹12 Cr | -17.53 | |
| Mar2022 | ₹14 Cr | -43.56 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹380.1 Cr | 9.7% | -2.8% | -22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | 9.7% |
-2.8% |
-22.1% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses